Severe asthma and the omalizumab option
<p>Abstract</p> <p>Atopic diseases and asthma are increasing at a remarkable rate on a global scale. It is now well recognized that asthma is a chronic inflammatory disease of the airways. The inflammatory process in many patients is driven by an immunoglobulin E (IgE)-dependent pr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-05-01
|
| Series: | Clinical and Molecular Allergy |
| Online Access: | http://www.clinicalmolecularallergy.com/content/6/1/4 |